References
- Sauermann R, Rothenburger M, Graninger W, Joukhadar C. Daptomycin: a review 4 years after first approval. Pharmacology 2008; 81: 79–91.
- Fowler VG Jr, Boucher HW, Corey GR, et al Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006; 355: 653–665.
- Baltz RH. Daptomycin: mechanisms of action and resistance, and biosynthetic engineering, Curr Opin Chem Biol 2009; 13: 144–151.
- Sader HS, Fritsche TR, Jones RN. Antimicrobial activity of daptomycin tested against clinical strains of indicated species isolated in North American medical centers (2003). Diagn Microbiol Infect Dis 2005; 53: 329–332.
- Sader HS, Fritsche TR, Streit JM, et al Daptomycin in vitro activity tested against Gram-positive strains collected from European and Latin American medical centers in 2003. J Chemother 2005; 17: 477–483.
- Biedenbach DJ, Bell JM, Sader HS, et al Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003–2004). Int J Antimicrob Agents 2007; 30: 143–149.
- Clinical and Laboratory Standards Institute. Methods for Dilution of Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. Approved standard M7-A8. 8th ed. Wayne, PA: CLSI: 2009.
- Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. Nineteenth Informational Supplement. M 100-S19. Wayne, PA: CLSI: 2009.
- Boucher HW, Sakoulas G. Perspectives on Daptomycin resistance, with emphasis on resistance in Staphylococcus aureus. Clin Infect Dis 2007; 45: 601–608.
- Arias CA, Torres HA, Singh KV, et al Failure of daptomycin monotherapy for endocarditis caused by an Enterococcus faecium strain with vancomycin-resistant and vancomycin-susceptible subpopulations and evidence of in vivo loss of the vanA gene cluster. Clin Infect Dis 2007; 45: 1343–1346.
- Coombs GW, Nimmo GR, Pearson JC, et al Australian Group for Antimicrobial Resistance. Prevalence of MRSA strains among Staphylococcus aureus isolated from outpatients, 2006. Commun Dis Intell 2009; 33: 10–20.
- Turnidge JD, Kotsanas D, Munckhof W, et al Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand. Med J Aust 2009; 191: 368–373.
- Huggan PJ, Wells JE, Browne M, et al Population-based epidemiology of Staphylococcus aureus bloodstream infection in Canterbury, New Zealand. Intern Med J 2010; 40(2): 117–125.